首页> 美国卫生研究院文献>Neuropsychiatric Disease and Treatment >Advances in the diagnosis of exosomal miRNAs in ischemic stroke
【2h】

Advances in the diagnosis of exosomal miRNAs in ischemic stroke

机译:缺血性脑卒中外泌体miRNA的诊断研究进展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Early diagnosis, early treatment, and improved prognosis in patients with ischemic stroke are vital requirements. Current clinical practices for the diagnosis of stroke include computed tomography, magnetic resonance imaging, and other traditional imaging methods to quickly check the location, volume, etc, in the hospital; however, diagnosis of the underlying cause of infarction is not effective with these practices. Owing to the coexistence of various etiologies, accurate and timely diagnosis using routine hematology and biochemical tests remains a challenge. Exosomes are membrane vesicles, approximately 30–150 nm in diameter, which fuse with cell membrane and are released into the extracellular space. As one of the research hotspots in the field of medicine in recent years, exosomes can participate in immune response, antigen presentation, cell migration, tumor invasion, and so on. Owing to the important role played by the miRNAs contained in exosomes, the latter have shown great potential in the diagnosis and treatment of ischemic stroke. This article reviews the progress made regarding the exosomal miRNAs as ischemic stroke biomarkers.
机译:缺血性中风患者的早期诊断,早期治疗和改善预后是至关重要的要求。当前诊断中风的临床实践包括计算机断层扫描,磁共振成像和其他传统成像方法,以快速检查医院的位置,体积等。但是,使用这些方法对梗塞的根本原因的诊断无效。由于多种病因并存,使用常规血液学和生化检查进行准确,及时的诊断仍然是一个挑战。外泌体是膜囊泡,直径约30-150 nm,与细胞膜融合并释放到细胞外空间。作为近年来医学领域的研究热点之一,外泌体可以参与免疫反应,抗原呈递,细胞迁移,肿瘤侵袭等。由于外来体中所含的miRNA发挥了重要作用,后者在缺血性中风的诊断和治疗中显示出巨大潜力。本文回顾了有关外泌体miRNAs作为缺血性中风生物标志物的研究进展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号